Leaders at miRagen Therapeutics Inc., a clinical-stage biopharmaceutical company that creates novel microRNA-based therapeutics, recently received the first portion of a Translational Research Advancing Therapy for ALS (TREAT ALS) grant.
Researchers from the University of California San Francisco Medical Center recently stated that, in honor of World MS Day, they want to design more therapies that will help patients with multiple sclerosis (MS) achieve greater independence.
AbbVie, a worldwide, research-focused biopharmaceutical company, recently announced that it will have representatives giving presentations that will be transmitted via webcast from the Jefferies 2016 Healthcare Conference on June 8.
DiversityComm Inc. recently listed Astellas as a leading employer in the pharmaceutical, health care and biotech industry, and 'Professional Woman’s Magazine' named Astellas a 'Best of the Best' employer.
Autism Speaks recently announced the recipient of its first Royal Arch Masons Predoctoral Fellowship, which is dedicated to encouraging careers focused on auditory processing among children diagnosed with autism.
Researchers at the National Cancer Institute, the University of Utah and the American Cancer Society recently conducted a study to show that U.S. patients who have HIV infections are not as likely to receive treatments for cancer.
The Lupus Foundation of America recently encouraged the people to join KNOW LUPUS, a nationwide effort to increase the funds and awareness that are important to creating a world with a future that doesn’t have lupus.